Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740200
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic StudyAap Ka ClinicCompleted
NCT07740200Completed
—
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician...Aap Ka Clinic
NCT07739810
Miniaturized Vital Sign Monitoring for Newborns in the Delivery RoomMcGill University Health Centre/Research Institute of the McGill University Health CentreNot Yet Recruiting
NCT07739810Not Yet Recruiting
—
Miniaturized Vital Sign Monitoring for Newborns in the Delivery RoomMcGill University Health...
NCT07738328
Terbinafine for CSA-AKI PreventionGuangdong Provincial People's HospitalNot Yet RecruitingPhase 2
NCT07739589
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal SystemAgile TherapeuticsCompletedPhase 4
NCT07739589Completed
Phase 4
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Eth...Agile Therapeutics
NCT07740616
Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer SurvivorsUniversity of Alabama at BirminghamNot Yet RecruitingNot Applicable
NCT07740616Not Yet Recruiting
Not Applicable
Speed of Processing Training to Improve Cognitive Functioning and Driving Perfor...University of Alabama at...
NCT07739069
Action Observation Versus Mirror Therapy in Children With Spastic Hemiplegic Cerebral PalsyCairo UniversityNot Yet RecruitingNot Applicable
NCT07739069Not Yet Recruiting
Not Applicable
Action Observation Versus Mirror Therapy in Children With Spastic Hemiplegic Cer...Cairo University
NCT07738497
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hospital of Zhejiang University School of MedicineNot Yet RecruitingNot Applicable
NCT07738497Not Yet Recruiting
Not Applicable
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hos...
NCT07738523
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB TrialHospital Universitario GetafeRecruitingPhase 2
NCT07738523Recruiting
Phase 2
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFI...Hospital Universitario Ge...
NCT07739355
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Combination of 5% Hydro-Urea, Ceramide, With MultiVesicular Emulsion Technology and Petrolatum on Dry Skin in the ElderlyDr. dr. Lili Legiawati, SpKK(K)CompletedPhase 3
NCT07739355Completed
Phase 3
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Comb...Dr. dr. Lili Legiawati, S...
NCT07740668
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After StrokeKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07740668Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Ov...Kutahya Health Sciences U...
NCT07739017
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals, Inc.Not Yet RecruitingPhase 1
NCT07739017Not Yet Recruiting
Phase 1
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals,...
NCT07739329
A Study on the Preventive Effect of Electroacupuncture Combined With Dexmedetomidine in Post-stroke DepressionMin SuNot Yet RecruitingPhase 4
NCT07739329Not Yet Recruiting
Phase 4
A Study on the Preventive Effect of Electroacupuncture Combined With Dexmedetomi...Min Su
NCT07739680
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce UniversityNot Yet RecruitingNot Applicable
NCT07739680Not Yet Recruiting
Not Applicable
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce University
NCT07739888
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNovartis PharmaceuticalsNot Yet RecruitingPhase 3
NCT07739888Not Yet Recruiting
Phase 3
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients Wi...Novartis Pharmaceuticals
NCT07739030
Prehospital and Acute Phase Characteristics of Severe Spontaneous ICHKirsten MollerCompleted
NCT07739030Completed
—
Prehospital and Acute Phase Characteristics of Severe Spontaneous ICHKirsten Moller
NCT07738796
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their MetabolitesPeking Union Medical College HospitalNot Yet Recruiting
NCT07738796Not Yet Recruiting
—
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associ...Peking Union Medical Coll...
NCT07740642
A Comparative Usability Study of Two Total Body Skin Imaging SystemsUniversity Hospital, Basel, SwitzerlandNot Yet Recruiting
NCT07740642Not Yet Recruiting
—
A Comparative Usability Study of Two Total Body Skin Imaging SystemsUniversity Hospital, Base...
NCT07738822
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHACullinan Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07738822Not Yet Recruiting
Phase 1
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wA...Cullinan Therapeutics Inc...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07740538
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy UniversityNot Yet Recruiting
NCT07740538Not Yet Recruiting
—
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy Universit...
Result Breakdown
Not yet recruiting14 (70%)
Completed5 (25%)
Recruiting1 (5%)
Not Specified6 (30%)
not_applicable6 (30%)
Phase 22 (10%)
Phase 42 (10%)
Phase 32 (10%)
Phase 12 (10%)